We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Ultrasound Contrast Agent Deemed Safe During Stress Echocardiogram

By MedImaging staff writers
Posted on 14 Jul 2008
Print article
Recent research has demonstrated that the use of ultrasound contrast agents during stress echocardiograms is safe.

These results, revealed by investigators from the Methodist DeBakey Heart & Vascular Center (Houston, TX, USA) at the 19th annual scientific sessions of the American Society of Echocardiography, held in June 2008, in Toronto, Ontario, Canada, come just months after the U.S. Food and Drug Administration (FDA) mandated a black box warning on the labels of contrast agents used for cardiovascular ultrasound.

The risk of major adverse effects is no different in patients that received contrast during their stress echocardiogram than in those who did not receive contrast, according to research findings. This was evident even though contrast was more frequently used in patients with a higher cardiac risk profile.

"Contrast-enhanced stress echocardiography is a safe option to attain important diagnostic information for patients who need more testing than cardiac ultrasound alone,” said Dr. Kamran Shaikh, postdoctoral echocardiography fellow at the Methodist DeBakey Heart & Vascular Center. "Our research found no link between its use and adverse events or any reason why it shouldn't be available to cardiologists whose patients would benefit from it.”

Contrast, a liquid that is distinctly visible in imaging studies such as echocardiograms, is injected into the heart to enhance the quality of the image. The study examined 3,121 consecutive patients who underwent stress echocardiograms from 2002 through 2007 at the Methodist Hospital (Dallas, TX, USA).

Researchers assessed demographics, contrast use, hemodynamics, electrocardiography (ECG), and wall motion changes, symptoms, and arrhythmias. Contrast was administered in 1,879 of 3,121 patients (60%). None of the patients receiving an ultrasound contrast agent experienced sustained ventricular tachycardia, ventricular fibrillation, cardiac arrest, or death.


Related Links:
Methodist DeBakey Heart & Vascular Center
New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
Doppler String Phantom
CIRS Model 043A
New
Diagnostic Ultrasound System
MS1700C
New
X-ray Diagnostic System
FDX Visionary-A

Print article
Radcal

Channels

Radiography

view channel
Image: The new X-ray detector produces a high-quality radiograph (Photo courtesy of ACS Central Science 2024, DOI: https://doi.org/10.1021/acscentsci.4c01296)

Highly Sensitive, Foldable Detector to Make X-Rays Safer

X-rays are widely used in diagnostic testing and industrial monitoring, from dental checkups to airport luggage scans. However, these high-energy rays emit ionizing radiation, which can pose risks after... Read more

MRI

view channel
Image: The scans revealed a new dimension of brain network organization in humans (Photo courtesy of Georgia State University/TReNDS Center Research)

New Approach Identifies Signatures of Chronic Brain Disorders Using fMRI Scans

Traditional studies of brain function, often using fMRI scans to detect brain activity patterns, have shown promise in identifying changes in individuals with chronic brain disorders like schizophrenia.... Read more

Nuclear Medicine

view channel
Image: Example of AI analysis of PET/CT images (Photo courtesy of Academic Radiology; DOI: 10.1016/j.acra.2024.08.043)

AI Analysis of PET/CT Images Predicts Side Effects of Immunotherapy in Lung Cancer

Immunotherapy has significantly advanced the treatment of primary lung cancer, but it can sometimes lead to a severe side effect known as interstitial lung disease. This condition is characterized by lung... Read more

General/Advanced Imaging

view channel
Image: Cleerly offers an AI-enabled CCTA solution for personalized, precise and measurable assessment of plaque, stenosis and ischemia (Photo courtesy of Cleerly)

AI-Enabled Plaque Assessments Help Cardiologists Identify High-Risk CAD Patients

Groundbreaking research has shown that a non-invasive, artificial intelligence (AI)-based analysis of cardiac computed tomography (CT) can predict severe heart-related events in patients exhibiting symptoms... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.